CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Enanta Pharmaceuticals Inc  (ENTA)
Other Ticker:  
 
 

ENTA's Revenue Growth by Quarter and Year

Enanta Pharmaceuticals Inc's Revenue results by quarter and year




ENTA Revenue (in millions $) FY 2018 FY 2017 FY 2016 FY 2015
IV Quarter September -139.42 75.93 12.84 14.42
III Quarter June 57.26 7.51 13.98 11.60
II Quarter March 44.05 8.96 13.00 57.37
I Quarter December 38.11 10.42 48.45 77.50
FY   - 102.82 88.27 160.89



ENTA Revenue forth quarter 2018 Y/Y Growth Comment
Enanta Pharmaceuticals Inc in the forth quarter recorded of $ -139.42 millions.

According to the results reported in the forth quarter, Enanta Pharmaceuticals Inc achieved the best Revenue growth in Major Pharmaceutical Preparations industry. While Enanta Pharmaceuticals Inc' s Revenue no change of % ranks overall at the positon no. in the forth quarter.




ENTA Revenue ( Y/Y Growth %) 2018
2017 2016 2015
IV Quarter September - 491.36 % -10.96 % 446.21 %
III Quarter June 662.45 % -46.28 % 20.52 % -72.41 %
II Quarter March 391.63 % -31.08 % -77.34 % 2556.02 %
I Quarter December 265.74 % -78.49 % -37.48 % 8607.87 %
FY   - 16.48 % -45.14 % -

Financial Statements
Enanta Pharmaceuticals Inc's forth quarter 2018 Revenue $ 0.00 millions ENTA's Income Statement
Enanta Pharmaceuticals Inc's forth quarter 2017 Revenue $ 0.00 millions Quarterly ENTA's Income Statement
New: More ENTA's historic Revenue Growth >>


ENTA Revenue (Quarter on Quarter Growth %)

2018
2017 2016 2015
IV Quarter September - 911.05 % -8.15 % 24.31 %
III Quarter June 29.99 % -16.18 % 7.54 % -79.78 %
II Quarter March 15.59 % -14.01 % -73.17 % -25.97 %
I Quarter December -49.81 % -18.85 % 235.99 % 2835.61 %
FY (Year on Year)   - 16.48 % -45.14 % -




Revenue forth quarter 2018 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Revenue forth quarter 2018 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Revenue by Quarter for the Fiscal Years 2015, 2016, 2017, 2018

Enanta Pharmaceuticals Inc's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ENTA's IV. Quarter Q/Q Revenue Comment
IV. Quarter 2018 results of -139.42 millions by Enanta Pharmaceuticals Inc come out even less good considering the 57.26 millions a quarter before.

Within Major Pharmaceutical Preparations industry Enanta Pharmaceuticals Inc achieved highest sequential Revenue growth. While Enanta Pharmaceuticals Inc's Revenue growth quarter on quarter, overall rank is .


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ENTA's IV. Quarter Q/Q Revenue Comment
Recent accomplishment of -139.42 millions by Enanta Pharmaceuticals Inc come out even less good compare to the 57.26 millions in the third quarter.

Within Major Pharmaceutical Preparations industry Enanta Pharmaceuticals Inc achieved highest sequential Revenue growth. While Enanta Pharmaceuticals Inc's Revenue growth quarter on quarter, overall rank is .


Enanta Pharmaceuticals Inc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2018)
12 Months Ending
(Jun 30 2018)
12 Months Ending
(Mar 31 2018)
12 Months Ending
(Dec 31 2017)
12 Months Ending
(Sep 30 2017)
Cumulative Revenue 12 Months Ending $ 0.00 $ 215.35 $ 165.60 $ 130.51 $ 102.81
Y / Y Revenue Growth (TTM) -100 % 442.05 % 258.47 % 159.77 % 16.48 %
Year on Year Revenue Growth Overall Ranking # 3194 # 50 # 98 # 129 # 3213
Seqeuential Revenue Change (TTM) -100 % 30.04 % 26.89 % 26.93 % 158.79 %
Seq. Revenue Growth (TTM) Overall Ranking # 3470 # 159 # 172 # 371 # 3489




Cumulative Revenue growth Comment
Enanta Pharmaceuticals Inc realized trailing twelve months of $ 0 millions, in the Sep 30 2018, compare to Revenue of $ 103 millions a year ago.

In the Healthcare sector 430 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 50 to 3194.

Revenue TTM Q/Q Growth Statistics
High Average Low
160.46 %
16.26 %
-100 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 140
Healthcare Sector # 431
Overall # 3194

Revenue TTM Y/Y Growth Statistics
High Average Low
442.05 %
95.39 %
-100 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 140
Sector # 475
S&P 500 # 3470
Cumulative Revenue growth Comment
Enanta Pharmaceuticals Inc realized trailing twelve months of $ 0 millions, in the Sep 30 2018, compare to Revenue of $ 103 millions a year ago.

In the Healthcare sector 430 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 50 to 3194.

Revenue TTM Q/Q Growth Statistics
High Average Low
160.46 %
16.26 %
-100 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 140
Healthcare Sector # 431
Overall # 3194

Revenue TTM Y/Y Growth Statistics
High Average Low
442.05 %
95.39 %
-100 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 140
Sector # 475
S&P 500 # 3470




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ENTA's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for ENTA's Competitors
Revenue Growth for Enanta Pharmaceuticals Inc's Suppliers
Revenue Growth for ENTA's Customers

You may also want to know
ENTA's Annual Growth Rates ENTA's Profitability Ratios ENTA's Asset Turnover Ratio ENTA's Dividend Growth
ENTA's Roe ENTA's Valuation Ratios ENTA's Financial Strength Ratios ENTA's Dividend Payout Ratio
ENTA's Roa ENTA's Inventory Turnover Ratio ENTA's Growth Rates ENTA's Dividend Comparisons



Companies with similar Revenue no change for the quarter ending Sep 30 2018 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2018
U.s. Stem Cell, Inc. -0.17 %$ -0.175 millions
Tg Therapeutics, Inc. -0.25 %$ -0.252 millions
Alphatec Holdings, Inc. -0.42 %$ -0.420 millions
Natures Sunshine Products Inc -0.53 %$ -0.530 millions
Chemocentryx, Inc. -0.60 %$ -0.598 millions
Capital Senior Living Corp -1.42 %$ -1.422 millions
Anika Therapeutics, Inc. -1.46 %$ -1.460 millions
Heska Corp -1.51 %$ -1.505 millions
Quest Diagnostics Inc -2.18 %$ -2.175 millions
Luminex Corp -2.28 %$ -2.281 millions
Avinger Inc -2.46 %$ -2.463 millions
Invacare Corporation -2.53 %$ -2.530 millions
Lemaitre Vascular Inc -2.65 %$ -2.647 millions
Birner Dental Management Services Inc -2.72 %$ -2.723 millions
Shineco, Inc. -2.82 %$ -2.822 millions
Allergan Plc -3.05 %$ -3.046 millions
American Shared Hospital Services -3.10 %$ -3.100 millions
Diversicare Healthcare Services, Inc. -3.38 %$ -3.379 millions
Aac Holdings, Inc. -3.67 %$ -3.669 millions
Bausch Health Companies Inc. -3.74 %$ -3.740 millions
Mylan N.v. -4.17 %$ -4.175 millions
Hca Healthcare, Inc. -4.31 %$ -4.312 millions
Radnet, Inc. -4.42 %$ -4.418 millions
Cleveland Biolabs Inc -4.57 %$ -4.572 millions
Icu Medical Inc -4.68 %$ -4.681 millions
Ocular Therapeutix, Inc. -4.78 %$ -4.780 millions
Brookdale Senior Living Inc. -4.92 %$ -4.917 millions
Infusystem Holdings, Inc -5.18 %$ -5.180 millions
Opko Health, Inc. -5.19 %$ -5.192 millions
Endo International Plc -5.26 %$ -5.264 millions


     
       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

PHIP's Profile

Stock Price

PHIP's Financials

Business Description

Fundamentals

Charts & Quotes

PHIP's News

Suppliers

PHIP's Competitors

Customers & Markets

Economic Indicators

PHIP's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071